Hanson & Doremus Investment Management
Position in JNJ — Johnson & Johnson
CIK 1393944
BURLINGTON, VT
Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,140,472
+$268,543 QoQ
Shares Held
16,303
+2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#1,748
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. JNJ ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,140,472 | 16,303 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,871,929 | 15,840 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,859,635 | 13,818 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,453,662 | 13,233 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,024,090 | 13,251 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,525,245 | 15,227 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,007,036 | 13,878 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,043,090 | 12,607 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,873,040 | 12,815 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,092,695 | 13,229 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $2,072,102 | 13,220 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,052,785 | 13,180 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,320,755 | 14,021 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,098,545 | 13,539 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,918,081 | 16,519 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $2,391,590 | 14,640 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,553,126 | 14,383 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,562,923 | 14,461 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $2,420,127 | 14,147 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,284,740 | 14,147 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $2,296,146 | 13,938 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,624,176 | 15,967 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,502,184 | 15,899 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,075,089 | 13,938 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,981,476 | 14,090 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $2,213,867 | 16,883 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||